bat

Credit Ratings: BAT

August 2026: S&P Global Assigns ‘BBB-‘ Rating to BAT’s Perpetual Subordinated Hybrid Instruments S&P Global Ratings has assigned a ‘BBB-‘ long-term issue rating to British

Read More »

BAT: H1 2026 Results

Ahead of H1 2026 Earnings Release Release date: July 30, 2026 (before the opening bell) Revenue: £12.19 billion (+1.0% reported, +3.0% at constant currency) Adj.

Read More »

BAT: H1 2026 Trading Update

Ahead of the H1 2026 Trading Update release Date: June 2, 2026 (Tuesday), before the bell FY26 Consensus: At constant currency, 3.4% Revenue, 4.3% Adjusted profit from

Read More »

Beyond Nicotine: BAT

April 2026: British American Tobacco Affiliate Holds 29.9% Stake in Organigram, With Path to 49% Organigram reported that its strategic investor, BT DE Investments, an

Read More »

BAT: FY25 Results

Release date: February 12, 2026; before the LSE opening Consensus ahead of the release: +1.9% revenue and 2.0% operating profit growth in FY25; Acceleration in

Read More »

BAT: FY25 Trading Update

Ahead of the FY25 Trading Update release Release date: December 9, 2025 (before the LSE opening bell) Consensus estimates: 2.1% revenue and 2.1% adj. operating

Read More »

BAT: H1 2025 Results

Ahead of H1 2025 Earnings release Release date: July 31, 2025 (before the opening bell) Revenue: £12.0 billion (-2.7% reported, +1.2% at constant currency) EPS:

Read More »

Reynolds

Reynolds Reinvented: 150 Years of Tobacco, Transformation, and Corporate Reinvention R.J. Reynolds Tobacco Company’s story is at once quintessentially American and quietly emblematic of the

Read More »

BAT: FY24 Results

Release date: February 13, 2025; before the LSE opening Consensus ahead of the release: +0.9% revenue and +1.3% operating profit growth in FY24; acceleration in

Read More »

BAT: 2024 Capital Markets Day

Ahead of the event, BAT re-confirmed its FY24 and medium-term financial targets: “on track to deliver low-single digit organic revenue and adjusted operating profit growth

Read More »

Share Buybacks: BAT 

July 2024 BAT enters into an agreement with Goldman Sachs to purchase ordinary BAT shares from July 25, 2024 to October 14, 2024. Thereby, Goldman

Read More »

BAT: H1 2024 Results

Top-line – Revenue: £12.34Bn (vs. £12.47Bn expected, down -0.8% on an organic basis) – Revenue from New Categories: £1.65Bn (vs. £1.69Bn expected, up +7.4%) –

Read More »

BAT: FY23 Results

Top-line – Revenue: £27.28Bn (vs. £27.9Bn expected) – Reported Revenue: down -1.3%, largely due to the sale of Russian business as well as the impact

Read More »

BAT – FY23 Results: Preview

Release date: February 8, 2023 (before the opening bell) BAT already released an Interim Business Update (IBU) on December 6, 2023. Recall: Our “BAT: Interim Business Update”

Read More »

The BAT – ITC Saga

ITC is the tobacco market leader in India, world’s most populous country, and is the fourth largest publicly-traded tobacco company in the world by market

Read More »

BAT: H1 2023 Results

Top-line – Revenue: £13.44Bn (vs. £13.3Bn expected) – Revenue up +2.8% (New Categories up +27.9%) – Revenue from New Categories: 12.3% of total Bottom-line –

Read More »

BAT: Trading Update

Key Highlights – On track to meet FY23 guidance – Disappointing US combustibles performance: but, the volume share has grown sequentially since the start of

Read More »

BAT: CEO Appointment

May 2023: New CEO The Board announces that – the current CEO is stepping down from the Board of Directors with immediate effect – the

Read More »

BAT: H2 & FY22 Results

Top-line & Bottom-line results Adjusted, at constant currencies Net revenue up +2.3% (New Category net revenue up +37%) Operating profit up +4.3%; operating margin +90

Read More »

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address